Furthermore, the GO and KEGG analysis of S-T, S-T–pathway network, and KEGG pathway enrichment of 10 common genes between regulated DEGs and S-T all indicated that HTJZD exerted therapeutic action on hyperlipidemia by modulating lipid metabolism and insulin resistance. This evidence concerns the gene INS and hyperlipidemia.